|
1)
Scope and limitations of the
designer proline-rich antibacterial peptide dimer, A3-APO, alone or in
synergy with conventional antibiotics.
Cassone M, Vogiatzi
P, La Montagna R, De Olivier Inacio V, Cudic P, Wade JD, Otvos L Jr.
Peptides.
2008 Nov;29(11):1878-86.
2)
Leptin signaling in breast
cancer: an overview.
Cirillo D, Rachiglio
AM, la Montagna R, Giordano A, Normanno N.
J Cell
Biochem.
2008 Nov 1;105(4):956-64. Review
3)
The antiretroviral nucleoside
analogue Abacavir reduces cell growth and promotes differentiation of
human medulloblastoma cells.
Rossi A, Russo G,
Puca A, La Montagna R, Caputo M, Mattioli E, Lopez M, Giordano A,
Pentimalli F.
Int J
Cancer.
2009 Jul 1;125(1):235-43.
4)
New pyrazolo-[3,4-d]-pyrimidine
derivative Src kinase inhibitors lead to cell cycle arrest and tumor
growth reduction of human medulloblastoma cells.
Rossi A, Schenone S,
Angelucci A, Cozzi M, Caracciolo V, Pentimalli F, Puca A, Pucci B, La
Montagna R, Bologna M, Botta M, Giordano A.
FASEB J.
2010 Aug;24(8):2881-92. Epub 2010 Mar 30.
5)
Adenosine receptor ligands in
clinical trials.
Rizzolio F, La
Montagna R, Tuccinardi T, Russo G, Caputi M, Giordano A.
Curr Top
Med Chem.
2010;10(10):1036-45.
|